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Summary
®The trypanocidal efficacy of ProZant Vet , a new ready to use 
generic brand of diminazene aceturate was compared with two 
®s tandard t r ypanoc ides ;  Trypamidium Samorin  
®(isometamidium chloride) and Dimivet  (diminazene 
diaceturate) in rats artificially infected with Trypanosoma 
congolense. Thirty albino rats (fifteen males and fifteen 
females) randomly divided into five groups (A, B, C, D and E) 
of six rats each were used for the study. Each group comprised 
three males and three females but each sex category was 
caged separately to avoid mating and pregnancy. Group C was 
the infected untreated control while group E was the uninfected 
untreated control. Groups A, B and D were infected with T. 
congolense and treated on day 14 post infection with 
®isometamidium chloride (Trypamidium Samorin ) at a dose of 
®2 mg/kg body weight, diminazene diaceturate (Dimivet ) and 
®diminazene aceturate (ProZant Vet ) at doses of 7 mg/kg 
body weight, respectively. Parameters used for assessing the 
efficacy of treatments including Packed Cell volume (PCV) 
Hemoglobin concentration (Hb) and parasitaemia showed 
®some variations between the drugs. Dimivet –treated group 
PCV and HB responses to trypanocidal administration were the 
best. Cases of relapse parasitaemia were recorded in all the 
three treated groups, which occurred earlier in the 
® ®Trypamidium–Samorin  and ProZant  treated groups (14 
®days, respectively, PI) compared with Dimivet  treated group 
R(21 days PI). All rats in the Trypamidium-Samorin  and 
RDimivet  groups died, whereas one rat in the ProZant group 
survived beyond the experimental period. A sex-related 
mortality pattern occurred which indicated greater 
susceptibility of the male than female rats.  After a careful 
consideration of our results, we concluded that there was no 
®appreciable difference between the efficacies of Dimivet  and 
®ProZant , but were apparently superior to Trypamidium – 
®Samorin . However, none of the drugs cured the infection to 
prevent incidences of relapse parasitaemia thus indicating that 
the T. congolense strain used in this study resisted the normal 
therapeutic dose of the drugs.  
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INTRODUCTION
The African Animal Trypanosomosis (AAT) has 
been described as a major obstacle to sustainable 
livestock production and food security, and 
according to Swallow (2000) is an important 
factor of underdevelopment in sub-Saharan 
Africa. The disease has an economic importance 
which is related to high morbidity and mortality 
of susceptible animals, and the high cost of 
treatment of such animals as well as a decreased 
production of meat and milk. It is the most single 
devastating disease in Africa in terms of poverty 
and loss of agricultural production amounting to 
3 billion pounds annually (Hursey, 2000). The 
disease is usually characterized by anemia (seen 
as pale mucous membrane, reduced packed cell 
volume and haemoglobin concentration) 
weakness, emaciation, fever, lethargy, weight 
loss and a heavy mortality rate (Urquhart et al., 
1996). Transmission is either mechanically by 
biting flies such as Tabanids, Stomoxys, Liperosa, 
and Haematopota or cyclically by tsetse fly 
belonging to the genus Glossina (Soulsby, 1986).
Chemotherapy and chemoprophylaxis, coupled 
with vector control programmes, have been the 
main stay of trypanosomosis control in Africa in 
the absence of effective vaccine against the 
disease. Drug control of animal trypanosomosis 
in Africa is mainly dependent on the use of 
diminazene and isometamidium chloride (Aliu 
et al., 1984; Aliu and Odegaard, 1985; Anika et 
al., 1987). Diminazene is a curative drug while 
isometamidium chloride, which has a long 
lasting action, is both curative and preventive 
trypanocide. Their continued use and 
effectiveness as a tool for the treatment and/or 
chemoprophylaxis of trypanosomosis has been 
threatened by the availability in the market of 
poor quality, substandard and adulterated 
veterinary products. Drugs used in animal 
trypanosomosis are generally subject to lower 
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standards of quality control than those used in 
human African trypanosomosis (Maudlin et al., 
2004). Multiple generic variants of trypanocidal 
drugs,  including isometamidium and 
diminazene are available and a recent analysis of 
commonly used diminazene preparations in the 
country has revealed some discrepancies in their 
drug quality (Anene et al., 2006). The release of 
preparations that contain low qualities of active 
drug creates ideal conditions for the selection of 
drug resistance as well as leading to therapeutic 
failures. It is thus important to evaluate any new 
trypanocidal formulation for its chemo-
therapeutic effectiveness before presentation 
and adoption for field use in any given area.       
In this study therefore, we have undertaken to 
evaluate the comparative trypanocidal efficacy 
®of ProZant , a new ready to use diminazene 
formulation against standard formulations of 
isometamidium chloride and diminazene 
aceturate in Trypanosoma congolense infected 
rats.   
MATERIALS AND METHOD
Experimental Animal
Thirty albino rats (fifteen males and fifteen 
females) bred in the animal house of the Faculty 
of Veterinary Medicine, University of Nigeria 
Nsukka were used for the experiment. They were 
kept in clean cages inside a well ventilated fly-
proof experimental animal house. They were 
humanely cared for in compliance with the 
principle of laboratory animal care. They were 
given food and clean water ad libitum 
throughout the experiment.
Trypanosoma congolense 
The Trypanosoma congolense was obtained from 
National Institute for Trypanosomiasis Research 
(NITR) Vom, Plateau State. It was isolated from a 
cow in Gwarzo area of Kaduna State in 2009. It 
was maintained by intra-peritoneal (p.i.) 
passage in white albino rats. 
Drugs
®ProZant Vet  (Neospark Drug and Chemicals 
Private Limited, 241, B.L. Bagh, Panjagutta, 
Hyderabad-500  082, A.P. , India). It was a 
ready to use injectable solution, containing 
diminazene aceturate and phenazone.
®Trypamidium-Samorin  (Merial, 29, Avenue 
Tony Gamier-69007-France).
®Trypamidium-Samorin  is a brand of 
isometamidium chloride. It was presented in 
125 mg sachet as a sterile red powder and 
was reconstituted with 6.25ml of sterile 
water to make 2% solution.
®Dimivet  (SKM Pharma PVT. Ltd, Nashik-
422 010, Bangalore-560 001, India). 
Dimivet is a 2.3g granules containing 1.05g 
of Diminazene diaceturate and reconstituted 
with 12.5ml of sterile water. 
Experimental Design
The rats were randomly divided into five groups 
(A, B, C, D and E) of six rats each. Each group was 
made up of three males and three females but 
each sex in each group was kept in a separate 
cage to avoid mating and pregnancy. Each of the 
rats in groups A, B, C and D was inoculated i.p. 
with Trypanosoma congolense infected rat blood 
6containing 2.6x10  trypanosomes per milliliter. 
Group E was used as the uninfected and 
untreated control. Group C was the infected but 
untreated control whereas on day 14 post 
infection, groups A, B and D rats were 
administered trypanocides i.p. as follows:
Group A: Isometamidium chloride (Trypami-
®dium-Samorin ) at a dose of 2 mg/kg body 
weight.
®Group B: Diminazene diaceturate (Dimivet ) at 
a dose of 7 mg/kg body weight.
®Group D: Diminazene aceturate (ProZant Vet ) 
at a dose of 7 mg/kg body weight. 
Parasitaemia by buffy coat method (Murray et 
al., 1977) and haematological parameters (PCV, 
Hb; Schalm et al., 1975) were measured weekly, 
except for daily tail blood examinations to 
determine parasite clearance time post 
treatment. Deaths were recorded daily. Blood 
samples for haematology were obtained by the 
orbital bleeding technique. The parameters were 
monitored for 63 days with the exception of 
parasitaemia which was monitored for 77 days 
to accommodate the sixty days recommended for 
the evaluation of drug sensitivity in trypanosome 
chemotherapy (Geerts and Holmes, 1998).
Statistical analysis
Data obtained were expressed as arithmetic 
mean ± s.e.m. Statistical significance was 
assessed using one-way analysis of variance 
(ANOVA) and Duncan's multiple range test with 
SPSS version 16 soft ware package.  P values < 
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0.05 were considered significant.
RESULTS
Parasitaemia
The results of the parasitaemia are presented in 
table I. The infection was patent by day 14 post 
infection (PI). The mean parasite clearance time 
® ®post treatment with Samorin , Dimivet ,  and  
®ProZant  was 72 ± 0.0, 48 ± 0.0 and 66 ± 15.6 
hours, respectively (not shown in the table). 
Relapse parasitaemia occurred with all of the 
three trypanocides used, and following re-
treatment of the relapse, parasite clearance time 
was 72 ± 19.6, 48 ± 0.0 and 48 ± 0.0 hours, 
respectively, for the drugs. The relapse interval 
®was 14 days post treatment for Samorin  and 
®ProZant , and 21 days post treatment for 
®Dimivet . 
Mortality
 All the infected untreated rats died by day 35 PI 
(Table I) with mean time to death (MTD) of 23.3 
± 3.6 days. Of the 12 infected male rats, seven 
(58%) died on day14 PI while none of the female 
infected rats died within this period. All the 
® ® Samorin  treated- and Dimivet treated-rats 
(100%) died by day 49 (MTD, 42.5 ± 3.7) and 
day 77 (MTD, 68.3 ± 2.3) PI, respectively, 
®whereas (83.3%) of ProZant  treated rats died 
by day 70 (MTD, 51.7 ± 9.7) PI, with one 
survival beyond the experimental period.
Packed cell volume (PCV)
Infection caused a significant decrease (P < 
0.05) in the PCV of the rats by day 14 PI (Table 
II). Trypanocidal administration reversed the 
haematocrit to normal values in all the treated 
groups by day 21 PI. It subsequently decreased 
®significantly (P< 0.05) in the Samorin -treated 
®group by day 28 PI, and in the Dimivet  and 
®ProZant -treated group by day 42 PI, being 
®significantly (P < 0.05)  lower in the Dimivet  
®  group compared with ProZant group.
Haemoglobin (Hb) Concentration 
The Hb concentration of all the infected groups 
significantly decreased (P < 0.05) by day 14 PI 
(Table III). Trypanocidal treatment caused 
significant improvement (P < 0.05) in the Hb 
®concentration by day 21 PI in the Dimivet  and 
® ®ProZant groups but not Samorin .
TABLE I: Parasitaemia of T. congolense infected rats treated with 
® ® ®either Samorin  Dimivet  or ProZant .
+   Day of treatment (trypanocide administration)
++   Day of re-treatment of relapsed infection in groups A and D.
+++   Day of re-treatment of relapsed infection in group B
* Number of rats parasitaemic; Denominator = the number of rats per group.
TABLE II: Mean PCV (%) ± SEM of T. congolense infected rats 
® ® ®treated with either Samorin , Dimivet  or ProZant
+   Day of treatment (trypanocide administration)                                        
+   Day of re-treatment of relapsed infection in groups A and D.   
+++   Day of re-treatment of relapsed infection in group B
Different superscripts in a row indicate significantly difference (p< 0.05).  
TABLE III: Mean haemoglobin concentration (gm/dl) ± SEM of T. 
® ®congolense infected rats treated with Samorin , Dimivet  or 
®ProZant .
+   Day of treatment (trypanocide administration)
++   Day of re-treatment of relapsed infection in groups A and D.
+++   Day of re-treatment of relapsed infection in group B.
 Different superscripts in a row indicate significantly difference (p< 0.05).
DISCUSSION 
The results of this study showed that T. 
congolense infection of rats produced patent 
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agreement with the findings of Abenga et al. 
(2005) and Ezeokonkwo (2009) but contrasted 
with the findings of Onyeyili and Anika (1991) 
and Anene et al. (1989) in T. congolense infected 
animals .  The parasi taemia increased 
progressively leading to the death of all the rats 
by day 35 PI, with greater susceptibility of the 
male rats than females similar to the finding of 
Turay et al. (2005). The course of T. congolense 
infection in this study was acutely fatal, similar 
to the finding of Ezeokonkwo (2009) but differs 
from that of Anene et al. (1989) in T. congolense 
infected dogs. Treatment with the three drugs 
cleared the parasites from the blood of the 
infected rats within 3 days of treatment but with 
varying levels of efficacy.
Relapse parasitaemia occurred at similar time 
interval (2 weeks post treatment) in the 
®Trypamidium-Samorin  and ProZant-treated 
®groups but was longer (3 weeks) in the Dimivet -
treated group. Relapse after trypanocidal 
treatment has been reported by other workers 
(Jennings et al., 1977; Peregrine et al., 1991; 
Sutherland et al., 1991). Relapse is usually 
considered to indicate resistance to the drug 
under test at the dose rate employed 
(Williamson and Stephen 1960; Ainanshe et al., 
1972). Relapse of infection can also occur due to 
the ability of the trypanosome to penetrate the 
brain and other intracellular tissue beyond the 
action of trypanocides which subsequently 
replicate and re-establish a circulating 
parasitaemia (Jennings and Gray 1983). 
®It is noteworthy, that one rat in the ProZant  – 
treated group survived beyond the period of this 
experiment, whereas survival was zero in the 
®Trypamidium – Samorin  – treated group by day 
®49 PI and in the Dimivet  - treated group by day 
77 PI. The results of the red blood cell 
parameters (PCV and Hb) showed that the 
infection of the rats with T. congolense caused 
anaemia consistent with the findings of other 
workers (Anosa, 1977; Ikede et al.,1977; 
Onyeyili and Anika, 1989; Anene et al., 1989). 
This decrease however, improved progressively 
following treatment to the level comparable with 
the uninfected control group before subsequent 
decreases initiated by recrudescence of parasites 
in the blood.
CONCLUSION 
It was concluded from the results of this study 
® ®that Dimivet  and ProZant  appeared to have 
comparable efficacies which were superior to 
®Trypamidium - Samorin  in the treatment of T. 
congolense infection, although none of the drugs 
was able to cure the infection and prevent 
relapses of infection. The far longer stability of 
ProZant in solution compared with the other 
trypanocides, which has financial benefit, 
confers great advantage to the drug.
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